Reporting methods in studies developing prognostic models in cancer: a review

scientific article

Reporting methods in studies developing prognostic models in cancer: a review is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1029966578
P356DOI10.1186/1741-7015-8-20
P932PMC publication ID2856521
P698PubMed publication ID20353578
P5875ResearchGate publication ID42767760

P50authorDouglas G. AltmanQ5300242
Patrick RoystonQ61959551
P2093author name stringSusan Mallett
Rachel Waters
Susan Dutton
P2860cites workMultivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsQ39605793
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapyQ40367091
Improvement of breast cancer relapse prediction in high risk intervals using artificial neural networksQ40377286
Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinomaQ40404767
International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases.Q40632659
Dangers of using "optimal" cutpoints in the evaluation of prognostic factorsQ40752297
Statistical aspects of prognostic factor studies in oncologyQ42388377
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimatesQ43796813
Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategyQ44234976
Regression modelling strategies for improved prognostic predictionQ44912226
Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selectionQ45255770
Prognosis and prognostic research: Developing a prognostic modelQ45768539
Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysisQ46329565
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation indexQ46513924
Prognosis and prognostic research: application and impact of prognostic models in clinical practiceQ46516876
Time-varying predictors for clinical surveillance of small hepatocellular carcinomaQ46626073
A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapyQ46652916
Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapyQ46731857
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.Q46748907
A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancerQ46905671
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemiaQ50128112
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomyQ24596735
Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic surveyQ24798774
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articlesQ29618882
Assessment and comparison of prognostic classification schemes for survival data.Q30581228
Searching for clinical prediction rules in MEDLINEQ30679969
Potential for selection bias with tumor tissue retrieval in molecular epidemiology studiesQ30719085
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelinesQ30937722
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group dataQ30979484
Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapyQ33222555
Reporting performance of prognostic models in cancer: a reviewQ33547696
What do we mean by validating a prognostic model?Q33849998
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patientsQ35597216
A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions.Q35965374
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomyQ36439622
The cost of dichotomising continuous variablesQ36468799
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Q36588459
A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's indexQ36614935
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic modelQ36615128
Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breastQ36616299
Reporting of multivariable methods in the medical literatureQ37271414
Prognostic models: a methodological framework and review of models for breast cancerQ37416515
Evaluation of logistic regression reporting in current obstetrics and gynecology literature.Q51895169
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.Q51962427
Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.Q52407317
A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.Q52409015
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.Q52975859
A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation.Q53354524
Reporting of Predictive Logistic Models Should Be Based on Evidence-Based GuidelinesQ57260094
The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based RegistryQ57304530
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade systemQ57846347
A population survival model for breast cancerQ58849647
A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMAQ59571876
Bootstrap investigation of the stability of a Cox regression modelQ69532872
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP systemQ80358653
Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndromeQ80392765
Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapyQ81129450
Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic careQ81147101
Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneityQ81170454
Prognostic index for adult patients with acute myeloid leukemia in first relapseQ81230380
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseQ81308465
A modified prognostic score for patients with curatively resected gastric cancerQ81313569
Dichotomizing continuous predictors in multiple regression: a bad ideaQ81336757
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinomaQ81341152
Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tractQ81396031
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomyQ81516651
A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expressionQ81625625
Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapyQ81639144
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapyQ81639266
Prognostic model of event-free survival for patients with androgen-independent prostate carcinomaQ81673391
Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomyQ81684119
Prognostic factors and a scoring system for patients with skeletal metastasisQ81690849
A new staging system for colorectal carcinoma with liver metastasisQ81704652
Recurrent epithelial ovarian cancer: validation and improvement of an established prognostic indexQ81752031
Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experienceQ81829537
Prognosis and prognostic research: what, why, and how?Q83391342
Prognosis and prognostic research: validating a prognostic modelQ83939735
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectneoplasmQ1216998
prognosticsQ3042561
predictive modellingQ7239673
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)20
P577publication date2010-03-30
P1433published inBMC MedicineQ4835947
P1476titleReporting methods in studies developing prognostic models in cancer: a review
P478volume8